[1]
2026. Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer. Journal of Cancer Research Updates. 15, 3 (Jul. 2026), 186–196. DOI:https://doi.org/10.30683/1929-2279.2026.15.17.